LARIMAR Trademark

Trademark Overview


On Friday, May 24, 2019, a trademark application was filed for LARIMAR with the United States Patent and Trademark Office. The USPTO has given the LARIMAR trademark a serial number of 88446118. The federal status of this trademark filing is REGISTERED as of Tuesday, February 14, 2023. This trademark is owned by Chondrial Therapeutics Inc.. The LARIMAR trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment of mitochondrial disorders; Pharmaceutical preparations and substances for treatment of genetic diseases; pharmaceutical preparations for the treatment of diseases or dysfunction of the mitochondria; pharmaceutical preparations featuring cell penetrating peptides for use in the treatment of genetic disorders; pharmaceuticals that treat genetic diseases by use of carrier proteins; pharmaceutical preparations for the treatment of ataxia; pharmaceutical preparations for the treatment of Friedreich's Ataxia; pharmaceutical preparations for protein replacement therapy

Pharmaceutical research and development; research and development in the pharmaceutical and biotechnology fields; research in the field of pharmaceuticals and drugs; conducting genomic analysis, pre-clinical studies and clinical trials for others in the field of pharmaceutical preparations for treatment of diseases
larimar

General Information


Serial Number88446118
Word MarkLARIMAR
Filing DateFriday, May 24, 2019
Status700 - REGISTERED
Status DateTuesday, February 14, 2023
Registration Number6980603
Registration DateTuesday, February 14, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 22, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of mitochondrial disorders; Pharmaceutical preparations and substances for treatment of genetic diseases; pharmaceutical preparations for the treatment of diseases or dysfunction of the mitochondria; pharmaceutical preparations featuring cell penetrating peptides for use in the treatment of genetic disorders; pharmaceuticals that treat genetic diseases by use of carrier proteins; pharmaceutical preparations for the treatment of ataxia; pharmaceutical preparations for the treatment of Friedreich's Ataxia; pharmaceutical preparations for protein replacement therapy
Goods and ServicesPharmaceutical research and development; research and development in the pharmaceutical and biotechnology fields; research in the field of pharmaceuticals and drugs; conducting genomic analysis, pre-clinical studies and clinical trials for others in the field of pharmaceutical preparations for treatment of diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, June 10, 2019
Primary Code005
First Use Anywhere DateFriday, September 30, 2022
First Use In Commerce DateFriday, September 30, 2022

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, June 10, 2019
Primary Code042
First Use Anywhere DateSaturday, November 30, 2019
First Use In Commerce DateSaturday, November 30, 2019

Trademark Owner History


Party NameLARIMAR THERAPEUTICS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBALA CYNWYD, PA 19004

Party NameLARIMAR THERAPEUTICS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressBALA CYNWYD, PA 19004

Party NameChondrial Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBala Cynwyd, PA 19004

Party NameChondrial Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBala Cynwyd, PA 19004

Trademark Events


Event DateEvent Description
Tuesday, February 14, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, February 14, 2023REGISTERED-PRINCIPAL REGISTER
Saturday, January 7, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, January 6, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, December 16, 2022STATEMENT OF USE PROCESSING COMPLETE
Tuesday, December 13, 2022USE AMENDMENT FILED
Tuesday, December 13, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, December 13, 2022ASSIGNED TO EXAMINER
Wednesday, August 31, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 30, 2022SOU EXTENSION 5 GRANTED
Thursday, June 9, 2022SOU EXTENSION 5 FILED
Monday, August 29, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, June 9, 2022TEAS EXTENSION RECEIVED
Saturday, December 18, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 16, 2021SOU EXTENSION 4 GRANTED
Thursday, December 16, 2021SOU EXTENSION 4 FILED
Thursday, December 16, 2021TEAS EXTENSION RECEIVED
Tuesday, June 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 21, 2021SOU EXTENSION 3 GRANTED
Monday, June 7, 2021SOU EXTENSION 3 FILED
Wednesday, June 16, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, June 14, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, June 7, 2021TEAS EXTENSION RECEIVED
Thursday, December 3, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 1, 2020SOU EXTENSION 2 GRANTED
Tuesday, December 1, 2020SOU EXTENSION 2 FILED
Tuesday, December 1, 2020TEAS EXTENSION RECEIVED
Tuesday, April 28, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 24, 2020SOU EXTENSION 1 GRANTED
Friday, April 24, 2020SOU EXTENSION 1 FILED
Friday, April 24, 2020TEAS EXTENSION RECEIVED
Tuesday, December 17, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 22, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 22, 2019PUBLISHED FOR OPPOSITION
Wednesday, October 2, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 17, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 17, 2019EXAMINER'S AMENDMENT ENTERED
Tuesday, September 17, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, September 17, 2019EXAMINERS AMENDMENT E-MAILED
Tuesday, September 17, 2019EXAMINERS AMENDMENT -WRITTEN
Tuesday, August 20, 2019NOTIFICATION OF PRIORITY ACTION E-MAILED
Tuesday, August 20, 2019PRIORITY ACTION E-MAILED
Tuesday, August 20, 2019PRIORITY ACTION WRITTEN
Tuesday, August 13, 2019ASSIGNED TO EXAMINER
Monday, June 10, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 28, 2019NEW APPLICATION ENTERED